Jiajing Cui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jiajing Cui has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Shuping Ren
Department of Occupational and Environmental Health, School of Public Health of Jilin University, China
5 shared publications - Dongge Liu
Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun 130021, China
3 shared publications - Pingwei Wang
Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun 130021, China
3 shared publications - Yujun Liang
Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun 130021, China
3 shared publications - Shuqi Yan
Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun 130021, China
2 shared publications Guolei Niu
School of Public Health, Capital Medical University, Beijing 100069, China
1 shared publication
Latest Publications
- 14 September 2026
- Published by Wiley in Journal of Applied Toxicology
Ferroptosis and Oxidative Stress Are Implicated Perfluorooctane Sulfonate‐Elicited Cytotoxicity to Human Umbilical Vein Endothelial Cells
Perfluorooctane sulfonic acid (PFOS) is one of the per‐ and polyfluoroalkyl substances (PFASs) that increases the risk of developing cardiovascular diseases (CVDs) closely related to endothelial damage. Ferroptosis is a new form of cell death involving multiple metabolic pathways; the role of ferroptosis in endothelial damage by PFOS is unknown. To investigate whether oxidative stress and ferroptosis mediate PFOS‐triggered endothelial injury, human umbilical vein endothelial cells (HUVECs) were exposed to PFOS with or without Fer‐1 intervention. Cellular function was evaluated via cell viability and migration assays. Markers associated with oxidative stress and ferroptosis were quantitatively detected, and the expression of relevant proteins was further analyzed using Western blot and immunofluorescence staining. Exposure to PFOS led to elevated reactive oxygen species (ROS), Fe 2+ accumulation, malondialdehyde (MDA) levels, and reduced glutathione (GSH) and glutathione peroxidase 4 (GPX4) expression. These changes were accompanied by impaired cell migration and alterations in endothelial function‐related indicators and vasoactive mediators. Fer‐1 intervention partially attenuated PFOS‐induced impairment. Further mechanistic analysis showed that PFOS triggered ferroptosis through inhibiting the SLC7A11–GSH–GPX4 pathway and stimulating oxidative stress signal cascades.
- 14 September 2026
- Published by Wiley in Journal of Applied Toxicology
Ferroptosis and Oxidative Stress Are Implicated Perfluorooctane Sulfonate‐Elicited Cytotoxicity to Human Umbilical Vein Endothelial Cells
Perfluorooctane sulfonic acid (PFOS) is one of the per‐ and polyfluoroalkyl substances (PFASs) that increases the risk of developing cardiovascular diseases (CVDs) closely related to endothelial damage. Ferroptosis is a new form of cell death involving multiple metabolic pathways; the role of ferroptosis in endothelial damage by PFOS is unknown. To investigate whether oxidative stress and ferroptosis mediate PFOS‐triggered endothelial injury, human umbilical vein endothelial cells (HUVECs) were exposed to PFOS with or without Fer‐1 intervention. Cellular function was evaluated via cell viability and migration assays. Markers associated with oxidative stress and ferroptosis were quantitatively detected, and the expression of relevant proteins was further analyzed using Western blot and immunofluorescence staining. Exposure to PFOS led to elevated reactive oxygen species (ROS), Fe 2+ accumulation, malondialdehyde (MDA) levels, and reduced glutathione (GSH) and glutathione peroxidase 4 (GPX4) expression. These changes were accompanied by impaired cell migration and alterations in endothelial function‐related indicators and vasoactive mediators. Fer‐1 intervention partially attenuated PFOS‐induced impairment. Further mechanistic analysis showed that PFOS triggered ferroptosis through inhibiting the SLC7A11–GSH–GPX4 pathway and stimulating oxidative stress signal cascades.
- Open Access
- 25 April 2024
- Published by Elsevier in Environment International
- Vol. 187, 108700
Low-level PM2.5 induces the occurrence of early pulmonary injury by regulating circ_0092363
- 25 April 2024
- Published by Elsevier in Environment International
- Vol. 187, 108700
Open AccessLow-level PM2.5 induces the occurrence of early pulmonary injury by regulating circ_0092363
- Open Access
- 1 January 2023
- Published by XMLink in Nutrition Research and Practice
- Vol. 17 (3) , 387-396
Effects of dietary salt intake restriction on blood glucose levels: a meta-analysis of crossover study
Shen Y, et al. Nutr Res Pract. 2023 Jun;17(3):387-396. https://doi.org/10.4162/nrp.2023.17.3.387
- 1 January 2023
- Published by XMLink in Nutrition Research and Practice
- Vol. 17 (3) , 387-396
Open AccessEffects of dietary salt intake restriction on blood glucose levels: a meta-analysis of crossover study
Shen Y, et al. Nutr Res Pract. 2023 Jun;17(3):387-396. https://doi.org/10.4162/nrp.2023.17.3.387
- Open Access
Perfluorooctane Sulfonate Induces Dysfunction of Human Umbilical Vein Endothelial Cells via Ferroptosis Pathway
(1) Background: Perfluorooctane sulfonate (PFOS) is a persistent organic pollutant, and it is receiving increasing attention regarding its human health risks due to its extensive use. Endothelial dysfunction is a mark of cardiovascular disease, but the basic mechanism of PFOS-induced endothelial dysfunction is still not fully understood. Ferroptosis is a newly defined regulatory cell death driven by cellular metabolism and iron-dependent lipid peroxidation. Although ferroptosis has been shown to be involved in the pathogenesis of cardiovascular diseases, the involvement of ferroptosis in the pathogenesis of endothelial dysfunction caused by PFOS remains unclear. (2) Purpose: To explore the role of ferroptosis in the dysfunction of endothelial cells and underlying mechanisms. (3) Methods: Human umbilical vein endothelial cells (HUVECs) were exposed to PFOS or PFOS and Fer-1. The viability, morphology change under electronic microscope, lipid-reactive oxygen species (lipid-ROS), and production of nitric oxide (NO) were determined. The expression of glutathione peroxidase 4(GPX4), ferritin heavy chain protein 1 (FTH1), heme oxygenase 1 (HO-1) and Acyl-CoA synthetase long-chain family member 4 (ACSL4) were analyzed via Western blot analysis. (4) Results: PFOS was shown to cause a decrease in viability and morphological changes of mitochondria, and well as an increase in lipid droplets. The expression of GPX4, FTH1 and HO-1 was decreased, and that of ACSL4 was increased after exposure to PFOS. In addition to the above-mentioned ferroptosis-related manifestations, there was also a reduction in NO content. (5) Conclusions: PFOS induces ferroptosis by regulating the GPX4 and ACSL4 pathways, which leads to HUVEC dysfunction.
Open AccessPerfluorooctane Sulfonate Induces Dysfunction of Human Umbilical Vein Endothelial Cells via Ferroptosis Pathway
(1) Background: Perfluorooctane sulfonate (PFOS) is a persistent organic pollutant, and it is receiving increasing attention regarding its human health risks due to its extensive use. Endothelial dysfunction is a mark of cardiovascular disease, but the basic mechanism of PFOS-induced endothelial dysfunction is still not fully understood. Ferroptosis is a newly defined regulatory cell death driven by cellular metabolism and iron-dependent lipid peroxidation. Although ferroptosis has been shown to be involved in the pathogenesis of cardiovascular diseases, the involvement of ferroptosis in the pathogenesis of endothelial dysfunction caused by PFOS remains unclear. (2) Purpose: To explore the role of ferroptosis in the dysfunction of endothelial cells and underlying mechanisms. (3) Methods: Human umbilical vein endothelial cells (HUVECs) were exposed to PFOS or PFOS and Fer-1. The viability, morphology change under electronic microscope, lipid-reactive oxygen species (lipid-ROS), and production of nitric oxide (NO) were determined. The expression of glutathione peroxidase 4(GPX4), ferritin heavy chain protein 1 (FTH1), heme oxygenase 1 (HO-1) and Acyl-CoA synthetase long-chain family member 4 (ACSL4) were analyzed via Western blot analysis. (4) Results: PFOS was shown to cause a decrease in viability and morphological changes of mitochondria, and well as an increase in lipid droplets. The expression of GPX4, FTH1 and HO-1 was decreased, and that of ACSL4 was increased after exposure to PFOS. In addition to the above-mentioned ferroptosis-related manifestations, there was also a reduction in NO content. (5) Conclusions: PFOS induces ferroptosis by regulating the GPX4 and ACSL4 pathways, which leads to HUVEC dysfunction.
- Open Access
The Role of Ferroptosis in the Damage of Human Proximal Tubule Epithelial Cells Caused by Perfluorooctane Sulfonate
Perfluorooctane sulfonate (PFOS) is a typical persistent organic pollutant and environmental endocrine disruptor that has been shown to be associated with the development of many diseases; it poses a considerable threat to the ecological environment and to human health. PFOS is known to cause damage to renal cells; however, studies of PFOS-induced ferroptosis in cells have not been reported. We used the CCK-8 method to detect cell viability, flow cytometry and immunofluorescence methods to detect ROS levels and Western blot to detect ferroptosis, endoplasmic reticulum stress, antioxidant and apoptosis-related proteins. In our study, we found that PFOS could induce the onset of ferroptosis in HK-2 cells with decreased GPx4 expression and elevated ACSL4 and FTH1 expression, which are hallmarks for the development of ferroptosis. In addition, PFOS-induced ferroptosis in HK-2 cells could be reversed by Fer-1. We also found that endoplasmic reticulum stress and its mediated apoptotic mechanism and P53-mediated antioxidant mechanism are involved in the toxic damage of cells by PFOS. In this paper, we demonstrated for the first time that PFOS can induce ferroptosis in HK-2 cells. In addition, we preliminarily explored other mechanisms of cytotoxic damage by PFOS, which provides a new idea to study the toxicity of PFOS as well as the damage to the kidney and its mechanism.
Open AccessThe Role of Ferroptosis in the Damage of Human Proximal Tubule Epithelial Cells Caused by Perfluorooctane Sulfonate
Perfluorooctane sulfonate (PFOS) is a typical persistent organic pollutant and environmental endocrine disruptor that has been shown to be associated with the development of many diseases; it poses a considerable threat to the ecological environment and to human health. PFOS is known to cause damage to renal cells; however, studies of PFOS-induced ferroptosis in cells have not been reported. We used the CCK-8 method to detect cell viability, flow cytometry and immunofluorescence methods to detect ROS levels and Western blot to detect ferroptosis, endoplasmic reticulum stress, antioxidant and apoptosis-related proteins. In our study, we found that PFOS could induce the onset of ferroptosis in HK-2 cells with decreased GPx4 expression and elevated ACSL4 and FTH1 expression, which are hallmarks for the development of ferroptosis. In addition, PFOS-induced ferroptosis in HK-2 cells could be reversed by Fer-1. We also found that endoplasmic reticulum stress and its mediated apoptotic mechanism and P53-mediated antioxidant mechanism are involved in the toxic damage of cells by PFOS. In this paper, we demonstrated for the first time that PFOS can induce ferroptosis in HK-2 cells. In addition, we preliminarily explored other mechanisms of cytotoxic damage by PFOS, which provides a new idea to study the toxicity of PFOS as well as the damage to the kidney and its mechanism.
- Open Access
Adverse Effects of Perfluorooctane Sulfonate on the Liver and Relevant Mechanisms
Perfluorooctane sulfonate (PFOS) is a persistent, widely present organic pollutant. PFOS can enter the human body through drinking water, ingestion of food, contact with utensils containing PFOS, and occupational exposure to PFOS, and can have adverse effects on human health. Increasing research shows that the liver is the major target of PFOS, and that PFOS can damage liver tissue and disrupt its function; however, the exact mechanisms remain unclear. In this study, we reviewed the adverse effects of PFOS on liver tissue and cells, as well as on liver function, to provide a reference for subsequent studies related to the toxicity of PFOS and liver injury caused by PFOS.
Open AccessAdverse Effects of Perfluorooctane Sulfonate on the Liver and Relevant Mechanisms
Perfluorooctane sulfonate (PFOS) is a persistent, widely present organic pollutant. PFOS can enter the human body through drinking water, ingestion of food, contact with utensils containing PFOS, and occupational exposure to PFOS, and can have adverse effects on human health. Increasing research shows that the liver is the major target of PFOS, and that PFOS can damage liver tissue and disrupt its function; however, the exact mechanisms remain unclear. In this study, we reviewed the adverse effects of PFOS on liver tissue and cells, as well as on liver function, to provide a reference for subsequent studies related to the toxicity of PFOS and liver injury caused by PFOS.